T. ROWE PRICE EQUITY SERIES, INC.

T. ROWE PRICE EQUITY SERIES, INC. (CIK 918294) is an SEC-registered fund company with 7 reporting fund series and $4.9B in net assets as of 2026-03-31.

Registrant

Fund series (7)

SeriesNet assets
T. Rowe Price Blue Chip Growth Portfolio$2.3B
T. Rowe Price Equity Income Portfolio$823.4M
T. Rowe Price Health Sciences Portfolio$662.6M
T. Rowe Price All-Cap Opportunities Portfolio$500.7M
T. Rowe Price Mid-Cap Growth Portfolio$429.6M
T. Rowe Price Moderate Allocation Portfolio$216.2M
T. Rowe Price Equity Index 500 Portfolio$22.0M

Largest reported holdings (across all series)

HoldingValue
ELI LILLY & CO$67.7M
THERMO FISHER SCIENTIFIC INC$27.0M
INTUITIVE SURGICAL INC$24.4M
STRYKER CORP$23.1M
MERCK & CO. INC.$22.9M
ASTRAZENECA PLC$21.0M
UNITEDHEALTH GROUP INC$20.5M
ARGENX SE - ADR$19.4M
ABBVIE INC$19.1M
REGENERON PHARMACEUTICALS$17.8M
GILEAD SCIENCES INC$17.3M
JOHNSON & JOHNSON$16.3M
VERTEX PHARMACEUTICALS INC$16.1M
DANAHER CORP$13.6M
ALNYLAM PHARMACEUTICALS INC$10.8M

More